Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : ABT-317
Catalog No.: PC-20543Not For Human Use, Lab Use Only.
ABT-317 (ABT317) is a potent, selective JAK1 inhibitor, inhibits IL-6-stimulated pSTAT3 (TF-1 cells, IC50=16 nM) and IL-2-stimulated pSTAT5 (T-blasts, IC50=30 nM).
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ABT-317 (ABT317) is a potent, selective JAK1 inhibitor, inhibits IL-6-stimulated pSTAT3 (TF-1 cells, IC50=16 nM) and IL-2-stimulated pSTAT5 (T-blasts, IC50=30 nM).
ABT 317 shows reduced potency against cytokine signaling pathways mediated by JAK2 (EPO-stimulated pSTAT5 in UT-7 cells, IC50 of 0.50 µM) or TYK2 (IL-12-stimulated pSTAT4 in T-blasts, IC50 of 0.25 µM).
ABT 317 blocks IFN-γ and common γ chain cytokine signaling in vitro.
ABT 317 reduces proinflammatory cytokine signaling in blood T cells and in β cells.
ABT 317 does not affect GM-CSF signaling or blood cell counts.
ABT 317 (10 mg/kg) reduces immune cell infiltration and T-cell proliferation, significantly reduces MHC class 1 expression on the β cell surface and reduces the proportion of CD45+ cells in islets in pre-diabetic NOD mice.
ABT 317 reduces the proportion of effector and memory CD8+ T cells in vivo, reverses newly diagnosed diabetes in NOD mice.
| M.Wt | ||
| Formula | ||
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
